Aidence Veye Lung Nodules
by DeepHealth (RadNet)
AI software for chest CT that detects and measures pulmonary nodules, compares scans, and supports radiologists’ lung-nodule workflow. It is marketed by DeepHealth following RadNet’s acquisition of Aidence.
Why Abandoned
DeepHealth currently lists and markets Veye Lung Nodules within its lung AI portfolio, indicating that the product remains commercially active after RadNet acquired Aidence.
🩺 Health Signals
- HTTP Status
- 200
- Response
- —
- SSL
- —
- Confidence
- 92%
- Domain expires
- —
- Last content change
- —
- Last tweet
- —
- API status
- —
📅 Timeline
Aidence founded
Mark-Jan Harte and Jeroen van Duffelen founded Aidence in Amsterdam to develop AI products for medical imaging.
Veye Lung Nodules receives CE marking
Aidence announced CE marking for Veye Lung Nodules, enabling commercial use of the chest CT analysis product in Europe.
RadNet agrees to acquire Aidence
RadNet announced an agreement to acquire Aidence and add its lung-nodule AI technology to RadNet’s expanding artificial-intelligence portfolio.
RadNet completes Aidence acquisition
RadNet reported completing the Aidence acquisition. Aidence subsequently became part of RadNet’s DeepHealth portfolio.
🔄 Alternatives to Aidence Veye Lung Nodules
Harvey AI
🟢ActiveHarvey launched in 2022 with a GPT-4-based product for case research, drafting, and document review tailored to elite law firms. Allen & Overy and PwC became flagship customers. By mid-2025 Harvey had raised over $500M across Sequoia, Kleiner, GV, and OpenAI's Startup Fund at a $5B+ valuation and counted most of the AmLaw 100 as customers. The product, team, and roadmap continue to grow.
Hugging Face
🟢ActiveThe GitHub of machine learning — hosting models, datasets, and AI applications.
🪦 Other dead Healthcare tools
Kheiron Mia
🟡Acquired / MergedMia is Kheiron Medical Technologies’ artificial intelligence platform for breast-screening mammography. It supports radiologists by analyzing mammograms and identifying cases that may warrant further review.
MaxQ AI ACCIPIO
🟠Possibly DeadACCIPIO was MaxQ AI's clinical AI platform for analyzing non-contrast head CT scans and prioritizing suspected intracranial hemorrhage cases for radiologist review. It was a triage aid, not a standalone diagnosis system.
Arterys Cardio AI
🟡Acquired / MergedCloud-based cardiac MRI analysis software that used machine learning to assist clinicians with image segmentation, ventricular measurements, and cardiac function assessment. Tempus acquired Arterys in 2022.
Zebra Medical Vision Imaging Analytics
🟡Acquired / MergedAI-based medical imaging analytics developed by Zebra Medical Vision to help identify findings in radiology scans. Nanox acquired Zebra in 2021 and incorporated its software into the Nanox.AI portfolio.
❓ Frequently Asked Questions
What is Aidence Veye Lung Nodules?
Veye Lung Nodules is AI-powered medical-imaging software that analyzes chest CT scans to help radiologists detect, measure, characterize, and track pulmonary nodules.
Is Aidence Veye Lung Nodules still available?
Yes. DeepHealth currently markets Veye Lung Nodules as part of its lung AI portfolio following RadNet’s acquisition of Aidence in 2022.
Who owns Aidence Veye Lung Nodules?
RadNet acquired Aidence in 2022. The product is now offered through DeepHealth, RadNet’s health informatics and AI business.
Does Veye Lung Nodules replace a radiologist?
No. It is clinical decision-support software intended to assist radiologists with chest CT review and lung-nodule management, not replace their professional interpretation.
What scans does Veye Lung Nodules analyze?
The product is designed for chest CT examinations. Its functions include finding pulmonary nodules, providing measurements, and supporting comparison with prior scans where available.